Please Note: This trial is no longer enrolling new participants
Phase 2 Trial of Selumetinib for the Prevention of Plexiform Neurofibroma Growth and Morbidity in Neurofibromatosis Type 1
| Protocol No. | PHO-NCTC-NF114 | Scope | National |
|---|---|---|---|
| Principal Investigator | Steven Rhodes | Treatment Type | Prevention |
| Age Group | Children | Phase | Phase II |
